Table 1.
Study | N | Cohen's d | Odds ratio | CI | Significance | Classification |
---|---|---|---|---|---|---|
Babbage et al., 2011 | 13 | −1.11 | −0.97 to −1.25 | * | Psychology | |
Bai, 2011 | 18 | 1.47 | 1.22–1.77 | * | Genetic | |
Björkhem-Bergman et al., 2011 | 6 | −1.20 | 1.60–8.00 | * | Treatment | |
Bucossi et al., 2011 | 21 | 0.41 | 0.17–0.65 | * | Neurochemistry | |
Chamberlain et al., 2011 | 11 | −0.51 | 0.83–1.08 | * | Psychology | |
Chang et al., 2011a | 56 | −0.19 | −0.29 to −0.10 | * | Psychology | |
Chang et al., 2011b | 6 | 0.98 | 0.86–1.12 | — | Genetic | |
Chen et al., 2011 | 12 | 0.60 | 0.52–0.69 | * | Miscellaneous | |
Chung and Chua, 2011 | 11 | 0.67 | 0.43–1.04 | — | Treatment | |
Domellöf et al., 2011 | 14 | 2.12 | 1.59–2.78 | * | Psychology | |
Etminan et al., 2011 | 14 | 0.80 | 0.70–0.92 | * | Treatment | |
Feng et al., 2011 | 4 | 1.20 | 1.04–1.40 | * | Genetic | |
Green et al., 2011 | 17 | −0.59 | −0.93 to −0.26 | * | Neurochemistry | |
Han et al., 2011 | 14 | 1.35 | 1.06–1.72 | * | Genetic | |
Hannestad et al., 2011 | 13 | −0.13 | −0.55 to 0.29 | — | Treatment | |
Hua et al., 2011 | 27 | 1.13 | 1.05–1.21 | * | Genetic | |
Lindson and Aveyard, 2011 | 8 | 1.05 | 0.92–1.19 | — | Treatment | |
Liu et al., 2011a | 12 | 1.04 | 0.88–1.22 | — | Genetic | |
Liu et al., 2011b | 6 | 0.89 | 0.82–0.96 | * | Genetic | |
MacKillop et al., 2011 | 57 | 0.58 | 0.51–0.64 | * | Psychology | |
Maneeton et al., 2011 | 5 | 1.67a | 1.23–2.26 | * | Treatment | |
Ohi et al., 2011 | 6 | 1.12 | 1.00–1.26 | * | Genetic | |
Olabi et al., 2011 | 14 | −0.40 | −0.62 to −0.19 | * | Brain imaging | |
Oldershaw et al., 2011 | 10 | −0.51 | −0.73 to −0.28 | * | Psychology | |
Oliver et al., 2011 | 7 | 0.86 | 0.79–0.95 | * | Treatment | |
Peerbooms et al., 2011 | 36 | 1.26 | 1.09–1.46 | * | Genetic | |
Pizzagalli, 2011 | 22 | 0.92 | 0.44–1.39 | * | Treatment | |
Rist et al., 2011 | 5 | 2.06 | 1.33–3.19 | * | Miscellaneous | |
Sexton et al., 2011 | 8 | 0.43 | 0.06–0.80 | * | Brain imaging | |
Shum et al., 2011 | 11 | 0.89 | 0.75–1.02 | * | Psychology | |
Sim et al., 2011 | 2 | 1.23a | 1.08–1.52 | * | Treatment | |
Song et al., 2011 | 12 | 0.15 | 0.04–0.26 | * | Neurochemistry | |
Sun et al., 2011 | 6 | 1.93 | 1.55–2.41 | * | Genetic | |
Tian et al., 2011 | 4 | 1.26 | 0.95–1.57 | * | Treatment | |
Trzesniak et al., 2011 | 11 | 1.98 | 1.33–2.94 | * | Brain imaging | |
Veehof et al., 2011 | 8 | 0.37 | 0.20–0.53 | * | Treatment | |
Vergouwen et al., 2011 | 24 | 0.83 | 0.74–0.93 | * | Treatment | |
Vieta et al., 2011 | 10 | 0.68a | 0.60–0.77 | * | Treatment | |
Wisdom et al., 2011 | 53 | −0.14 | −0.21 to −0.07 | * | Genetic | |
Witteman et al., 2011 | 26 | −1.41 | −1.76 to −1.05 | * | Psychology | |
Woon and Hedges, 2011 | 24 | −0.60 | −0.83 to −0.37 | * | Brain imaging | |
Xuan et al., 2011 | 20 | 1.00 | 0.86–1.16 | — | Genetic | |
Yang et al., 2011a, cohort | 14 | 1.38a | 1.18–1.61 | * | Miscellaneous | |
Yang et al., 2011a, case–control | 7 | 2.48 | 1.93–3.19 | * | Miscellaneous | |
Yang et al., 2011b | 3 | 0.67 | 0.43–0.92 | * | Treatment | |
Yuan et al., 2011 | 14 | 4.98 | 3.97–6.23 | * | Genetic | |
Zafar et al., 2011 | 8 | 1.07a | 0.91–1.27 | — | Treatment | |
Zhang et al., 2011 | 12 | 1.27 | 1.01–1.59 | * | Genetic | |
Zhu et al., 2011 | 8 | 0.84 | 0.18–1.49 | * | Brain imaging |
Classification performed by two independent raters.
aRelative risk.
*p < 0.05.